Method and probes for the genetic diagnosis of hemochromatosis
CA 2408263 A1 · Owner: Viennalab Labordiagnostika Gmbh · Inventors: Oberkanins, Christian; Gasparini, Paolo; De Villiers, Nico
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method to diagnose hemochromatosis includes examining a biological sample for the presence of a G .fwdarw. A mutation at nucleotide 506 and/or a G .fwdarw. T mutation at nucleotide 502 and/or of a G .fwdarw. C mutation at nucleotide 502 of the HFE cDNA sequence and/or by examining the biological sample for the presence of a C .fwdarw. G mutation at nucleotide 750 and/or a T .fwdarw. A mutation at nucleotide 515 and/or a frameshift mutation by insertion of a cytosine in a polyC tract at nucleotides 84-88 of the TFR2 cDNA sequence or examining a biological sample for the presence of respective amino acid substitutions. Probes according to the invention are capable of hybridizing …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 30, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 30, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 30, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.